Phosphorylated tau-Aβ42 ratio as a continuous trait for biomarker discovery for early-stage Alzheimer's disease in multiplex immunoassay panels of cerebrospinal fluid. uri icon

authors

  • Harari, Oscar
  • Morris, John C
  • Goate, Alison M
  • Cruchaga, Carlos
  • Kauwe, John S K
  • Ainscough, Benjamin J
  • Bales, Kelly
  • Pickering, Eve H
  • Bertelsen, Sarah
  • Fagan, Anne M
  • David M. Holtzman, MD

publication date

  • January 1, 2014